Margins in emerging markets are now higher than in China. But winning there takes more than low prices.In this episode, we look at how a Chinese medtech firm deployed its lab automation system in one of Southeast Romania’s largest hospitals—and helped cut lab operating costs by 34%.
Not through subsidies. Not through discounts. But by streamlining workflows, consolidating testing platforms, and delivering measurable operational value.This isn’t just a case study. It’s a signal:
In markets under pressure, companies that lead with innovation—not price—are starting to win.
What drives success across markets is universal: Innovation that customers feel in their bottom line.
#CNQQ #Rayliant #China NextGen tech wave #EmergingMarkets #MedTech #HealthTech #Automation #DeepTech #GlobalTrends #Investing
